XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Unaudited Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023   40,609,915    
Beginning balance at Dec. 31, 2023 $ 26,532 $ 40 $ 271,594 $ (245,102)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares)   1,579    
Exercise of stock options 2   2  
Stock-based compensation 1,057   1,057  
Sale of common stock under Open Market Sales Agreement, net of issuance costs (in shares)   931,250    
Sale of common stock under Open Market Sales Agreement, net of issuance costs 2,282 $ 1 2,281  
Net loss (18,978)     (18,978)
Ending balance (in shares) at Mar. 31, 2024   41,542,744    
Ending balance at Mar. 31, 2024 $ 10,895 $ 41 274,934 (264,080)
Beginning balance (in shares) at Dec. 31, 2024 41,750,109 41,750,109    
Beginning balance at Dec. 31, 2024 $ (27,909) $ 41 277,629 (305,579)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares) 37,987 37,987    
Exercise of stock options $ 5   5  
Stock-based compensation 508   508  
Net loss $ (9,266)     (9,266)
Ending balance (in shares) at Mar. 31, 2025 41,788,096 41,788,096    
Ending balance at Mar. 31, 2025 $ (36,662) $ 41 $ 278,142 $ (314,845)